Cargando…
Treatment repurposing for inflammatory bowel disease using literature-related discovery and innovation
Inflammatory bowel disease (IBD) incidence has been increasing steadily, most dramatically in the Western developed countries. Treatment often includes lifelong immunosuppressive therapy and surgery. There is a critical need to reduce the burden of IBD and to discover medical therapies with better e...
Autores principales: | Kostoff, Ronald Neil, Briggs, Michael Brandon, Shores, Darla Roye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7476176/ https://www.ncbi.nlm.nih.gov/pubmed/32952337 http://dx.doi.org/10.3748/wjg.v26.i33.4889 |
Ejemplares similares
-
Common contributing factors to COVID-19 and inflammatory bowel disease
por: Kostoff, Ronald Neil, et al.
Publicado: (2021) -
Antimicrobial peptides and the gut microbiome in inflammatory bowel disease
por: Gubatan, John, et al.
Publicado: (2021) -
Colorectal cancer screening and surveillance in patients with inflammatory bowel disease in 2021
por: Huguet, Jose Maria, et al.
Publicado: (2022) -
Orphan patients with inflammatory bowel disease - when we treat beyond evidence
por: Privitera, Giuseppe, et al.
Publicado: (2021) -
Literature-related discovery and innovation — update
por: Kostoff, Ronald N.
Publicado: (2012)